131 related articles for article (PubMed ID: 7643458)
1. [Effects of lactitol on fecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy].
Tarao K; Tamai S; Ito Y; Okawa S; Hayashi M
Nihon Shokakibyo Gakkai Zasshi; 1995 Jul; 92(7):1037-50. PubMed ID: 7643458
[TBL] [Abstract][Full Text] [Related]
2. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.
Riggio O; Varriale M; Testore GP; Di Rosa R; Di Rosa E; Merli M; Romiti A; Candiani C; Capocaccia L
J Clin Gastroenterol; 1990 Aug; 12(4):433-6. PubMed ID: 2398251
[TBL] [Abstract][Full Text] [Related]
3. [Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
Scevola D; Zambelli A; Concia E; Perversi L; Candiani C
Clin Ter; 1989 Apr; 129(2):105-11. PubMed ID: 2525995
[TBL] [Abstract][Full Text] [Related]
4. The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.
Merli M; Caschera M; Piat C; Pinto G; Diofebi M; Riggio O
J Clin Gastroenterol; 1992 Sep; 15(2):125-7. PubMed ID: 1401823
[TBL] [Abstract][Full Text] [Related]
5. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
[TBL] [Abstract][Full Text] [Related]
6. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy.
Salerno F; Moser P; Maggi A; Vitaliani G; Benetti G
J Hepatol; 1994 Dec; 21(6):1092-6. PubMed ID: 7699233
[TBL] [Abstract][Full Text] [Related]
8. Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
Masini A; Efrati C; Merli M; Attili AF; Amodio P; Ceccanti M; Riggio O
Am J Gastroenterol; 1999 Nov; 94(11):3323-7. PubMed ID: 10566738
[TBL] [Abstract][Full Text] [Related]
9. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
10. Effects of lactitol [correction of lactilol] on hepatic encephalopathy and plasma amino-acid imbalance.
Trovato GM; Catalano D; Carpinteri G; Runcio N; Mazzone O
Recenti Prog Med; 1995; 86(7-8):299-303. PubMed ID: 7569287
[TBL] [Abstract][Full Text] [Related]
11. [The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K; Suzuki K; Sato S
Nihon Yakurigaku Zasshi; 1995 May; 105(5):389-402. PubMed ID: 7628787
[TBL] [Abstract][Full Text] [Related]
12. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
[TBL] [Abstract][Full Text] [Related]
13. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
Morgan MY; Hawley KE
Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
15. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
Heredia D; Caballería J; Arroyo V; Ravelli G; Rodés J
J Hepatol; 1987 Jun; 4(3):293-8. PubMed ID: 3598162
[TBL] [Abstract][Full Text] [Related]
16. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
Morgan MY; Hawley KE; Stambuk D
J Hepatol; 1987 Apr; 4(2):236-44. PubMed ID: 3295020
[TBL] [Abstract][Full Text] [Related]
17. [Significance of fecal Bacteroides in hepatic encephalopathy with hyperammonemia].
Tarao K
Kansenshogaku Zasshi; 1986 Jan; 60(1):15-24. PubMed ID: 3088172
[No Abstract] [Full Text] [Related]
18. The effect of lactulose on the faecal flora of patients with hepatic encephalopathy.
Vince A; Zeegen R; Drinkwater JE; O'Grady F; Dawson AM
J Med Microbiol; 1974 May; 7(2):163-8. PubMed ID: 4600290
[No Abstract] [Full Text] [Related]
19. A non-absorbable rifamycin for treatment of hepatic encephalopathy.
Testa R; Eftimiadi C; Sukkar GS; De Leo C; Rovida S; Schito GC; Celle G
Drugs Exp Clin Res; 1985; 11(6):387-92. PubMed ID: 3836135
[TBL] [Abstract][Full Text] [Related]
20. Review article: bacterial flora and pathogenesis in hepatic encephalopathy.
Williams R
Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():17-22. PubMed ID: 17295848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
